NCT02091531 2019-11-21Dual mTOR Inhibitor MLN0128 in Advanced Castration-Resistant Prostate Cancer (CRPC) PatientsMemorial Sloan Kettering Cancer CenterPhase 2 Completed9 enrolled 10 charts